A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. and related parties, accusing them of orchestrating a pump-and-dump scheme during the company's IPO. The lawsuit alleges that stolen identities of financial advisors were used to promote the stock with false claims, leading to a dramatic 93% share price collapse on July 8, 2025. Investors who bought shares between December 27, 2024, and July 8, 2025, can seek lead plaintiff status until September 28, 2026. The case is ongoing in the Southern District of New York, with law firm Morris Kandinov LLP representing the plaintiffs.
UBS has set a new price target of $36 for Sirius XM Holdings, suggesting a 16.35% upside from its current price of $30.94. Sirius XM reported Q2 earnings of $0.70 per share, below the $0.78 consensus but up from $0.57 a year ago, showing earnings gro...
Freddie Mac reported Q2 earnings per share of $1.19, surpassing analyst expectations of $0.89, signaling robust profitability. Although quarterly revenue was slightly below forecasts at $5.99 billion versus $6.04 billion expected, the company maintai...
VINCI released its half-year financial report for 2026, showing a 2% increase in revenue, including a 4% growth in the second quarter. EBITDA also rose by 4%, reflecting solid operational performance. The company highlights its commitment to sustaina...
VINCI published its half-year financial report for 2026, highlighting a 2% increase in revenue, including 4% growth in the second quarter. The company also reported a 4% rise in EBITDA and significant growth in earnings per share, reflecting strong o...
Orange published its interim financial report for the first half of 2026, showing a 3.5% increase in revenue and a 5.0% rise in EBITDAaL. The company continues to lead in telecommunications across Europe, Africa, and the Middle East, connecting 340 m...
